Adam Maeder
Stock Analyst at Piper Sandler
(0)
# 3832
Out of 5,218 analysts
123
Total ratings
55.38%
Success rate
-0.06%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Vicarious Surgical | Maintains: Neutral | 12 11 | 14.2 | -26.06% | 6 | Nov 13, 2024 | |
Nevro | Maintains: Underweight | 7 6 | 4.08 | 47.06% | 15 | Nov 12, 2024 | |
Inspire Medical Syst... | Reiterates: Overweight | 255 260 | 188.34 | 38.05% | 13 | Nov 5, 2024 | |
Inari Medical | Maintains: Neutral | 50 52 | 55.66 | -6.58% | 6 | Oct 29, 2024 | |
Edwards Lifesciences | Maintains: Neutral | 73 70 | 73.33 | -4.54% | 12 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 495 538 | 539.38 | -0.26% | 17 | Oct 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 131 133 | 113.45 | 17.23% | 2 | Oct 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 2.97 | 51.52% | 3 | Sep 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 20 21 | 16.52 | 27.12% | 2 | May 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 20 | n/a | n/a | 6 | May 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 290 360 | n/a | n/a | 10 | Apr 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 8 | 1.12 | 614.29% | 1 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 15 20 | 7.99 | 150.31% | 8 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 75 71 | n/a | n/a | 8 | Jan 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 25 30 | 17.95 | 67.13% | 2 | May 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 6 5 | 2.35 | 112.77% | 2 | Mar 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 10 18 | 8.16 | 120.59% | 2 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 104 99 | 51.57 | 91.97% | 3 | May 5, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 9 11 | n/a | n/a | 5 | Jun 14, 2021 |